Celiac disease (CD) is an increasingly common disease that may affect as many as 1 % of the North American population. Recent population-based data suggest a substantial increase in the prevalence of CD over the last several decades. Several factors are hypothesized as possible disease triggers including intercurrent illnesses, such as gastroenteritis, surgeries, and trauma. We used the active duty US military, a unique healthy worker population with essentially complete medical diagnostic coding, as an opportunity to describe trends in CD and deployment-related risk factors.
INTRODUCTION
Celiac disease (CD) is an increasingly common disorder that may aff ect as much as 1 % of the North American population. It is known to aff ect all ages, including young adults, and may be more prevalent in Caucasians ( 1 ) . Th e rate of diagnosis in other racial groups is largely unknown. However, due to the broad spectrum of clinical presentation, and, until recently, the unavailability of sensitive and specifi c diagnostics, most aff ected individuals are never diagnosed ( 2 ) . Th e consequence of the disease may be diverse in terms of issues such as bone fragility, depressed resistance to bacterial and fungal infections, reduced ability to respond to vaccinations, and a variety of other nutritional, immunological, and infl ammatory comorbidities. Th e majority of CD patients have 1 of 2 HLAs encoded by genes that are also found in approximately one-third of the North American population. Considering that virtually the entire population consumes food containing signifi cant amounts of the primary exogenous trigger (i.e., gluten), yet only 1 % of the population may get the disease, research has been conducted to identify other
The Incidence and Risk of Celiac Disease in a Healthy US Adult Population Table 1 Total incidence (per 100,000) ( 4 ) . Other triggers include the seasonality of birth and risk of disease ( 5 ) . In addition, intercurrent illnesses, such as surgeries, and trauma, are potential triggers. Th e role of infection early in life, especially in those that overlap with the introduction of highdose gluten follow-on formulas that are oft en used aft er weaning, may be particularly likely to increase the rate of disease. Recent population-based data suggest a substantial increase in the prevalence of CD over the last several decades ( 6 -9 ) . Th is increase is unlikely to be due to a change in human genetics or population changes in wheat consumption, but may refl ect a change in other environmental factors. It has also recurred in adults, a phenomenon that may be more marked in North America than in Europe. In this study, we aim to explore the recent incidence and risk factors of CD in one of the largest and best documented adult populations in North America of active service personnel. Th is population includes substantial diversity of race and ethnicity and education level.
METHODS

Database information
Data were obtained from the Defense Medical Surveillance System, the main repository for medical data of Department of Defense benefi ciaries maintained by the Armed Forces Health Surveillance Center ( 10, 11 ) . All subjects were active duty US military personnel who served between 1999 and 2008. Medical information was derived from ambulatory and inpatient claims data for care provided within the Military Health System. Demographic data were derived from personnel information; deployment data were derived from deployment rosters and deployment health assessments. Included data were linked at the individual level and compiled into a single de-identifi ed data set, which was provided to the study investigators. Th e study was reviewed and approved by the Naval Medical Research Center Institutional Review Board in compliance with all appli cable regulations governing the protection of human subjects.
CD case identifi cation and control selection
A CD case was identifi ed when the service member had at least two ICD9-CM (579.0) specifi c medical encounters for a CD diagnosis within 6 months. Subsequent medical encounters were determined to be related to the CD if the International Classifi cation of Diseases, Ninth Revision, Clinical Modifi cation (ICD9-CM) code was included in any of the diagnostic positions. Each case was matched by time (a medical encounter within 1 calendar year), sex, and age (within 1 year) with up to four controls with an unrelated diagnosis randomly selected from the population that produced the cases (i.e., active duty military personnel). Baseline medical encounters for the control subjects included vaccinations, procedures, or other unrelated diagnoses. Incident CD was defi ned as the fi rst documented ambulatory or inpatient medical encounter with the ICD9-CM code listed above. Given that the military generally would not enlist COLON/SMALL BOWEL Riddle et al.
or commission a service member with known CD, it is unlikely that many of the incident CD diagnoses would include individuals who have a prior diagnosis of CD, though undiagnosed disease could be prevalent among both cases and controls selected.
Exposure
Th e primary exposure variable of interest was infectious gastroenteritis (IGE) at any time before a diagnosis of an incident CD (cases) or censure (controls). An IGE exposure was defi ned by ICD9-CM codes for specifi c pathogens and non-specifi c infectious enteritis as previously reported ( 12 ) . Non-specifi c IGE codes were included due to the lack of routine microbiology performed on patients with IGE in similar health-care settings ( 13 ) . Both specifi c and non-specifi c codes were utilized to classify an exposure as a specifi c bacterial, non-specifi c bacterial, protozoal, or viral etiology. We also evaluated exposures at 24, 18, 12, and 6 months before CD diagnosis or censure (controls) to assess the temporal relationship between exposure and outcome. While previous studies have evaluated associations of exposure up to 1 year, we chose to extend exposure windows up until 24 months to account for potential in diagnostic delay due to patient ' s care seeking behavior and / or provider diagnosis ( 14 ) , and we saw no signifi cant changes in eff ect estimates with diff erential exposure windows. Due to similarities in clinical presentation between the primary exposure (IGE) and symptoms of the CD outcome of interest, we evaluated a 6-month diagnostic delay window whereby exposures occurring within 6 months before CD diagnosis (or censoring for controls) were excluded ( 12 ) . In addition to IGE exposure, other demographic variables available in the data were evaluated, including race, military rank, educational attainment, marital status, and branch of service.
Analysis
CD incidence was estimated using the number of incident cases in a given year and the total number of active duty service members for that same year. Th e associations between CD, IGE, and covariates were initially explored by univariate methods. All analyses evaluated each CD independently. Univariate and multivariate conditional logistic regression models were used to evaluate the relationship between IGE, other covariates, and CD. For multivariate models, a backwards elimination approach was used, whereby all variables were initially added to the models. Th e variable with the largest insignifi cant P value was removed, and the models were refi t. Th is process was continued iteratively until all variables retained in the models were signifi cant at the α = 0.15 level ( 15 ) . Eff ect modifi cation was assessed statistically utilizing a multiplicative approach. Th e association of psychological comorbidity among cases and controls was also evaluated, but limited to concomitant diagnosis for initial CD visit of incident diagnosis and at censure visit for controls.
Statistical analyses were performed using SAS v. 8.2 for Windows (SAS Institute, Cary, NC). Two-tailed statistical signifi cance was evaluated using an α of 0.05. Table 1 , a total of 455 cases of incident CD were identifi ed in active duty US military personnel between 1999 and 2008 with an overall incidence of 3.55 per 100,000 person-years (p-yrs) (95 % confi dence interval (CI): 3.24, 3.90; Table 1 ). Rates were higher in females (7.70 per 100,000 p-yrs) compared with males (2.78 per 100,000 p-yrs) ( P < 0.001). Incidence for CD was noted to rise from 1.32 per 100,000 p-yrs in 1999 to 6.54 per 100,000 p-yrs in 2008, and this rise was highest in the older age strata ( Figure 1 ). While incidence increased at a higher rate per annum in whites, those classifi ed as other race (i.e., non-white and non-black) also showed year-over-year increases of ~ 0.8 per 100,000 per year.
RESULTS
As shown in
Th e majority of cases and controls were male (65.9 % ), white (66.4 % ), and married (69.4 % ) ( Table 2 ). Cases were noted to have education beyond high school (54.7 % ), which was higher than controls (45.8 % ) ( P < 0.001). Th e three major branches of the US Military Armed Forces (Army, Navy, and Air Force) comprised the majority (88.6 % ) of the study population, with most classifi ed as enlisted personnel, though a higher proportion of offi cers were noted among CD cases compared with controls (32.5 vs. 22.1 % , P < 0.001). Overlap with functional and other gastrointestinal disorders were assessed among cases and included dyspepsia (8 / 455, 1.8 % ), constipation (10 / 455, 2.2 % ), irritable bowel syndrome (20 / 455, 4.4 % ), and functional diarrhea (4 / 455, 0.9 % ). Th ere was no overlap with gastroesophageal refl ux disease. Overall, 38 (8.4 % ) had one or more visit associated with these gastrointestinal disorders. One-hundred seventy-two subjects had one or more IGE exposures with etiological category distributed as follows: bacterial pathogens ( n = 4, 2.3 % ), protozoal ( n = 2, 1.2 % ), viral ( n = 104, 60.5 % ), and other ( n = 74, 43.0). Among incident CD cases followed, the median number of visits was two (interquartile range: 2, 4) with no signifi cant diff erence based on exposure. Data were not available on the proportion of CD cases that resulted in discharge from medical service, though this is oft en known to occur in these cases (personal communication, Brooks Cash, US Navy).
Initial univariate analyses ( Table 3 ) found that the following covariates were independently associated with an increased risk of CD: Caucasian race, non-Army branch of service, greater than high-school education, and previous IGE episode. Prior deployment to Operation Iraqi Freedom deployment had lower risk of CD compared with non-Operation Iraqi Freedom deployers. Th e odds ratio (OR) for incident CD following an antecedent episode of IGE increased as the time frame allotted for exposure decreased. When limiting the IGE episodes to only those of non-viral origin in the 24 months before censure, the associated OR increased for CD. In a multivariate model, aft er controlling for the other covariates, being married, having less than a Bachelor ' s Degree, being in the Army, having an episode of IGE in the 24 months before censure signifi cantly increased the risk of each functional gastrointestinal disorder (FGD) ( Table 4 ). In contrast, being in the Marines appeared to be protective (Navy referent). Being classifi ed as nonCaucasian decreased the risk of CD.
DISCUSSION
Th is study demonstrates a substantial increased incidence and diagnosis rate of CD in a large, generally healthy young adult population for which there is excellent capture of diagnosis and ready access to health care. Th is rise in incidence is consistent with what has been reported in other western industrialized population-based studies ( 9,16 ) and likely represents a combination of both increased diagnoses due to increased suspicion but also may refl ect a true increase in incidence possibly related to environmental changes in cereal processing including wheat genetics, bread processing, and enzymatic modifi cation of wheat prolamins resulting from changes in industry processes ( 17 ) . It is interesting that this increase in incidence seemed to be more marked in individuals in the third, fourth, and fi ft h decades in life, among those who would have already been in the military service for many years, suggesting that this is a true new onset of disease or the emergence of longstanding silent disease. We did not have
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hepatitis C, non-viral disorders including insulin-dependent diabetes, thyroid disease and cardiomyopathy, and HIV ( 22, 23 ) . Th is suggests that the association may involve chronic immune stimulation, which in turn triggers an autoimmune reaction.
In the present study, we found an increased odds ratio of exposure to prior IGE twice as high among CD cases compared with matched controls (OR: 2.0, 95 % CI: 1.4, 2.8). Non-viral IGE exposure odds were relatively higher (OR: 3.0, 95 % CI: 1.9, 4.8), and odds of exposure were higher when looking at temporal proximity to CD diagnosis. Unfortunately, we do not have specifi c pathogen etiologies associated with these infections, and while these results are intriguing, the potential for misclassifi cation of exposure given the confl ated symptomatology of infectious diarrhea and CD confounds the potential association in this study. While much is known about the pathogenic adaptive and innate immune responses associated the disease process, less is known about the initiating steps that are involved in disease onset. As demonstrated in animal models of gluten sensitivity ( 24, 25 ) , gastrointestinal infection may trigger or facilitate the onset of clinical CD, either by increasing intestinal permeability or by enhancing uptake and dysfunctional anti-gliadin immune response in the genetically susceptible host ( 26, 27 ) . It is reasonable to suspect that acute gastrointestinal infections could result in the translocation of luminal antigens, including incompletely digested gluten peptides, which in the background of proinfl ammatory anti-bacterial responses could trigger a maladaptive immune response ( 2 ) . Campylobacter jejuni , a leading cause of enterocolitis worldwide, has been shown experimentally to permit the translocation of normal, non-invasive microfl ora via novel processes that implicate epithelial lipid raft s and M-cell transport and induce a pro-infl ammatory response ( 28 -30 ) . Th us, similarly to the epidemiological studies observing Campylobacter and Salmonella infections as a trigger of infl ammatory bowel disease ( 31, 32 ) it is possible that such infections could also trigger luminal antigens, including gluten peptides, across the intestinal barrier, and in certain susceptible individuals prime a mucosal immune response toward such antigens resulting in loss of tolerance to these antigens due to an inappropriate infl ammatory response ( 33, 34 ) .
With regard to what is known about infectious diarrhea as a trigger for CD there are a few anecdotal reports and case series suggesting an association whereby some patients with CD oft en attribute the onset of classic symptoms to a stressful episode or gastroenteritis ( 35 ) , and cases of CD have been reported as presenting as persistent travelers ' diarrhea when no infectious cause could be documented ( 36, 37 ) . It has also been described that exposure to three or more IGE events in young children at or around the time of introduction of follow-on formula was associated with a substantial increased risk of childhood diagnosis of CD ( 38 ) . In addition, a birth cohort followed in Denver suggested that rotovirus infection in the fi rst year of life was associated with subsequent risk for CD ( 3 ) . More recently, a case of a healthy subject who developed sudden irritable bowel syndrome-like symptoms aft er a confi rmed episode of C. jejuni enteritis was subsequently diagnosed with new onset CD ( 39 ) . It is interesting that in this study, we found a higher risk of CD in subjects who were diagnosed with a " non-viral " IGE episode. While the ICD-9-based diagnosis is data available on secular trends for number of serological CD tests performed, which should be done to inform the potential bias associated with increased testing that could partially explain the increased incidence (studies planned) ( 16 ) .
Clearly, environmental, genetic, and immunological factors have a role in the pathogenesis of CD. It is well accepted that the common HLA genotype encoding HLA types DQ2 or DQ8 is necessary for CD to occur ( 18 ) . However, as almost 30 % of the Caucasian population carries these genotypes, and virtually all eat gluten, there must be other factors including genetics, immune dysfunction, and environmental exposures that trigger the disease. Extensive genetic analysis has revealed a large number of other genes that all have very small attributable risks that cumulatively only add 10 % of risk ( 19 ) . Th e balance of genetic and environmental infl uences in risk of disease is also supported by the 75 % concordance in monozygous twin studies ( 20 ) . Although the only welldocumented environmental trigger is gliadin, it has been proposed that the clinical expression of CD can be modulated by environmental factors. It is possible that in genetically susceptible patients, an infectious insult may contribute to trigger overt CD through increased intestinal permeability, or adjuvant eff ects of infection or infl ammation, latent CD may be unmasked.
Given the potential for infections to act as triggers for developing gluten intolerance through molecular mimicry or other immune modulation mechanisms, eff orts to identify an infectious association have be made. However, to date, there is no compelling evidence for such an association ( 21 ) . Neonatal infections have been associated with increased risk of CD, and the role of adenovirus 12 virus remains controversial. Based on the 12 amino-acid homology sequence of adenovirus type 12 E1B protein and α -gliadin, it has been suggested that exposure to adenovirus type 12 E1B may sensitize individuals to gliadin and trigger CD. However, it is diffi cult to establish a causative relationship between adenovirus type 12 E1B and gliadin, because adenovirus type 12 E1B is also highly prevalent in the duodenal tissue of normal individuals ( 22 ) . CD is epidemiologically associated with other viral infections, such as chronic non-specifi c, it would suggest that bacterial infections could be more associated with subsequent diagnosis of CD. In total, the results we found lend support to the infectious trigger hypothesis, though this study relied on non-specifi c (and potentially misclassifi ed) infectious gastrointestinal exposures, which needs confi rmation through studies evaluating risk aft er pathogen-specifi c exposures. While CD is known to predominantly aff ect Caucasians, less is known about the incidence of CD in non-Caucasians. As this cohort of active military service personnel incorporates large numbers of individuals who are non-Caucasian, with unhindered access to medical care, the low incidence seen in non-Caucasians likely refl ects a true diff erence in biologic predisposition, although rates increased during the study period that may implicate secular trends in environmental infl uences which has been seen in infl ammatory bowel disease rates among non-whites ( 40 ) . It is unlikely that there would be signifi cant diff erences in environmental exposures or diet due to common food and preparation and provision with the military service, though it is possible that there may be inherently lower suspicion for CD by the medical personnel caring for individuals who are non-Caucasian. Future active surveillance study should be considered including sampling of non-Caucasians to verify that incidence is truly lower and not simply undiagnosed.
Other US military population specifi c diff erences were noted. Th e association of CD with offi cer rank and higher educational level begets the positive association with socioeconomic status. Th is has been suggested in an epidemiologic study from Finland wherein there is a higher rate of CD in the more developed population of Finland than the adjacent less developed population ( 41 ) . It is, however, possible that educational levels may have lead to increased awareness of this diagnosis, and also there may be a negative association with smoking for which we could not control.
Interestingly, we found that deployment decreased the risk of CD that may be counterintuitive given the known high risk of infectious exposures, including gastrointestinal infections, and stress while deployed. Unfortunately, capture of deployment-related illness and injury into the Defense Medical Surveillance System (DMSS) medical encounter databases is not complete; therefore, assessment of deployment-related illness eff ects (particularly minor ones) is incomplete. Furthermore, military members with underlying medical illness may not be deployed resulting in a type of " healthy worker " eff ect, which might also explain the lower rate of CD in deployed personnel compared with their non-deployed counterparts. Surgical stress has been described to trigger CD ( 42 ) , and future studies should be designed to capture these data to further evaluate deployment-related infectious and non-infectious exposures of interest.
Th is study has several limitations. First, an important limitation is that CD diagnoses were based on a medical encounter database, and while we believe our strategy for determining case status is robust based on prior experience with other complex diseases ( 12,43 -45 ) it is not possible to review individual medical records to confi rm. Additional studies are needed (and being planned) that use clinical procedure codes associated with upper endo scopy and histology, as well as serological evidence from linked Department of Defense serum repository specimens. Furthermore, given our reliance on clinically diagnosed CD, our incidence estimates should be considered as a gross underestimate of the true incidence in the population, though we feel the secular trends and diff erential rates among demographic subgroups are relevant observations. Second, as mentioned, the precise identifi cation of enteropathogens associated with IGE visits was not described, due to the fact that laboratory work-up of these infections is infrequently carried out in US military as well as in civilian clinics and emergency rooms. Furthermore, our stratifi cation of IGE into viral and non-viral categories is imprecise. It is further possible that these gastroenteritis episodes that were called IGE may actually have represented short-lived symptom events associated with subsequently diagnosed CD. To assess for such an eff ect, we utilized a 6-month exposure exclusion period before initial CD diagnosis (or control censoring) to prevent misclassifi cation of initial CD presentation as an episode of IGE, and we did not see such eff ect (data not shown). However, if the duration between exposure and disease onset is short, then we may have underrepresented the true association biasing the results toward the null. Additionally, to minimize potential misclassifi cation, this study excluded functional gastrointestinal disorders among controls and did not include such medical encounter visits before onset of incident CD. While not directly addressing this potential source of bias, excluding CD cases with functional gastrointestinal disorders co-diagnoses in this study did not change in the primary eff ect estimate of any IGE exposure (adjusted-OR: 2.00, 95 % CI: 1.37 -2.90). Finally, this study cohort does not address CD in the elderly or in the very young, and indeed individuals with chronic ill health are generally not admitted into military service; hence, this study may underestimate the true incidence in the general population.
In summary, our study shows a substantial increase in the rate of CD diagnosis in adult healthy Caucasian population with a much lower but increasing incidence in non-Caucasians. Th e disease is more likely to be diagnosed aft er a proximate IGE event of a non-viral nature and contribute to the emerging body of data that warrants further prospective or seroepidemiological studies linking pathogen-specifi c infectious diarrhea exposure attribution to incident CD. Studies that aim to evaluate the instigating exposures and mechanisms of CD-related antibody development, or initiation of disease in those who were previously asymptomatic but with pre-existence of positive celiac serology are needed (planned).
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